Table 5.
Cell labeling indices determined with PCNA immunostaining during the 13-week prechronic inhalation studies with decalin and propylene glycol mono-t-butyl ether.
Propylene glycol mono-t-butyl ether | Chamber Control | 75 ppm | 150 ppm | 300 ppm | 600 ppm | 1,200 ppm |
---|---|---|---|---|---|---|
Labeling index (%) n = 5 | ||||||
Week 2 | 3.6 ± 0.1 | 3.6 ± 0.2 | 3.9 ± 0.2 | 3.4 ± 0.1 | 4.4 ± 0.2* | 5.5 ± 0.4** |
Week 6 | 3.6 ± 0.1 | 3.2 ± 0.1 | 3.4 ± 0.2 | 3.9 ± 0.1 | 4.3 ± 0.0* | 4.9 ± 0.3* |
Week 13 | 3.2 ± 0.2 | 3.8 ± 0.2 | 4.3 ± 0.2** | 4.1 ± 0.2* | 5.0 ± 0.4** | 6.6 ± 0.4** |
Decalin | Chamber Control | 25 ppm | 50 ppm | 100 ppm | 200 ppm | 400 ppm |
Labeling index (%) n = 5 | ||||||
Week 2 | 3.3 ± 0.2 | 4.2 ± 0.1* | 3.9 ± 0.3 | 4.3 ± 0.2** | 4.2 ± 0.3* | 4.9 ± 0.3** |
Week 6 | 3.2 ± 0.1 | 4.2 ± 0.1** | 4.8 ± 0.1** | 4.6 ± 0.3** | 5.0 ± 0.2** | 5.9 ± 0.3** |
Week 13 | 3.1 ± 0.2 | 4.5 ± 0.1** | 3.7 ± 0.3* | 4.1 ± 0.2* | 4.5 ± 0.2** | 4.5 ± 0.2** |
Significantly different (p < 0.05) from the chamber control group.
p < 0.01, data are presented as mean + S.E.